Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Antex Biologics' Campylobacter vaccine shows promise in phase II

Jan. 11, 2001

ID Biomedical seeks clearance to initiate phase I/II clinical trial of StreptAvax

Jan. 11, 2001

Successful completion of phase I trial with Isotechnika's new immunosuppressant

Jan. 10, 2001

Licensing opportunity from NIH: virus-like particles as unlinked adjuvants

Jan. 8, 2001

InterMune seeks approval for Actimmune in Canada; initiates separate phase II trial

Jan. 4, 2001

FDA agrees to review BLA for first intranasal flu vaccine

Jan. 3, 2001

New potassium channel modulators synthesized and tested by NeuroSearch

Jan. 2, 2001

VX-148 enters clinical development

Dec. 22, 2000

Treatment of autoimmune diseases with Rituxan

Dec. 20, 2000

Proinflammatory cytokines downregulated by Vasogen's immune modulation therapy

Dec. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...